Navigating peptide procurement for advanced cellular and neuronal models requires rigorous analytical verification. PX1 Research provides batch-specific, independent third-party analytical documentation for every lot of Pinealon to ensure total sequence fidelity and raw chemical purity. Researchers can review full spectroscopic and chromatographic validation before integrating this short peptide bioregulator into experimental protocols.
Navigating peptide procurement for advanced cellular and neuronal models requires rigorous analytical verification. PX1 Research provides batch-specific, independent third-party analytical documentation for every lot of Pinealon to ensure total sequence fidelity and raw chemical purity. Researchers can review full spectroscopic and chromatographic validation before integrating this short peptide bioregulator into experimental protocols.
A pinealon third party tested standard requires independent ISO 17025 laboratory verification via Reverse-Phase High-Performance Liquid Chromatography (RP-HPLC) for chromatographic purity and Electrospray Ionization Mass Spectrometry (ESI-MS) for molecular weight and sequence confirmation. Authentic analytical reports must also quantify bacterial endotoxins via Limulus Amebocyte Lysate (LAL) testing to prevent cellular toxicity in sensitive in vitro models.
At PX1 Research, every production batch of Pinealon 10mg undergoes rigorous independent analysis before release. Our published Certificates of Analysis (COA) confirm chemical purity exceeding 98%, exact peptide mass, and endotoxin levels maintained well below standard cell-culture tolerances. This strict analytical protocol eliminates batch-to-batch variability in laboratory assays.
Pinealon is a synthetic tripeptide composed of L-glutamic acid, L-aspartic acid, and L-arginine, represented chemically by the amino acid sequence Glu-Asp-Arg (E-D-R). With a molecular formula of C15H26N6O8 and a theoretical molecular weight of approximately 390.35 g/mol, this short peptide bioregulator belongs to a distinct class of low-molecular-weight gene-regulatory compounds.
Unlike large recombinant proteins or complex trophic factors, short synthetic peptides cross biological membranes with distinct kinetic profiles. In vitro models suggest that small peptide sequences like Glu-Asp-Arg can interact directly with the nucleosome matrix, binding specific promoter regions within the major groove of DNA. Researchers investigating epigenetic regulation utilize Pinealon to evaluate how short-chain peptide sequences influence gene transcription without requiring active transport machinery.
To explore similar low-molecular-weight sequence motifs, researchers frequently browse our comprehensive catalog of all peptides for complementary experimental reagents.
The scientific literature surrounding Pinealon focuses primarily on central nervous system models, neuronal stress responses, and age-related cellular dysfunction. Preclinical rodent models and primary neuronal cultures have demonstrated that the Glu-Asp-Arg sequence modulates reactive oxygen species (ROS) accumulation during induced hypoxic or ischemic stress conditions.
In vitro assays using rodent cortical and hippocampal cell cultures indicate that Pinealon exposure correlates with preserved mitochondrial membrane potential and reduced apoptotic markers following oxidative insult. Transcriptomic profiling suggests that these protective phenomena are mediated through the upregulation of endogenous antioxidant enzymes, including superoxide dismutase (SOD) and glutathione peroxidase (GPx).
Furthermore, researchers studying cellular aging utilize Pinealon to observe its impact on caspase-3 activity and necrosis rates in senescent neuronal populations. Epigenetic investigations reveal that the tripeptide modulates chromatin accessibility, altering the expression patterns of genes involved in synaptic plasticity and protein synthesis. These findings position Pinealon as a primary compound for investigating nuclear-cytoplasmic signaling pathways in short-chain bioregulators research.
Peptide synthesis utilizing solid-phase peptide synthesis (SPPS) inherently produces deletion sequences, truncated peptides, diastereomers, and residual chemical reagents such as trifluoroacetic acid (TFA), piperidine, and organic solvents. Without rigorous post-synthesis purification and third-party verification, these impurities introduce uncontrollable variables into laboratory experiments.
Unverified peptide preparations often contain unknown quantities of TFA counterions, which alter local pH in unbuffered culture media and induce non-specific cytotoxicity. Furthermore, truncated peptide sequences can act as competitive antagonists or unpredicted ligands, generating false-positive or irreproducible transcriptomic data. Obtaining a pinealon third party tested batch ensures that these synthetic side-products are removed, isolating the physiological effect strictly to the target Glu-Asp-Arg molecule.
For critical cellular assays where subtle gene expression shifts are measured, relying on manufacturer self-testing is insufficient. Independent verification guarantees that chemical identity, stoichiometry, and purity are verified by neutral analytical chemists operating under strict quality control standards.
PX1 Research employs a three-tier analytical screening protocol for every lot of Pinealon. The primary purity assessment is conducted using Reverse-Phase High-Performance Liquid Chromatography (RP-HPLC). In this assay, the peptide sample is eluted across a C18 stationary phase using a gradient of acetonitrile and water containing 0.1% TFA. Chromatographic purity is defined by the relative peak area of the primary analyte compared to all secondary degradation or side-product peaks at 214 nm and 220 nm absorption wavelengths.
Identity verification is performed using Electrospray Ionization Mass Spectrometry (ESI-MS). ESI-MS generates multiply charged gas-phase ions that pass through a mass analyzer to determine the exact mass-to-charge ratio (m/z). A valid COA must display a dominant single spectrum corresponding precisely to the monoisotopic mass of Glu-Asp-Arg (390.35 Da), confirming the absence of wrong-sequence assembly or incomplete deprotection.
Finally, bacterial endotoxin content is measured using a chromogenic or turbidimetric Limulus Amebocyte Lysate (LAL) assay. Endotoxins (lipopolysaccharides) from Gram-negative bacteria induce strong inflammatory signaling in macrophage and neuronal cultures, skewing immunological and stress-response data. PX1 Research enforces an industry-leading endotoxin limit of less than 0.01 EU/μg, ensuring compatibility with sensitive in vitro and organoid systems. Review full details in our accessible research library.
Evaluating a third-party COA requires verifying key structural elements to confirm validity and traceability. A legitimate report must detail the specific lot number matching the physical vial label, the manufacturing date, testing date, and the identity of the independent ISO 17025 accredited laboratory.
The document must feature a clear RP-HPLC chromatogram showing a sharp, singular target peak with minimal baseline drift, alongside an explicit integrated peak area table confirming >98% purity. The accompanying ESI-MS spectrum must clearly identify the primary mass peak without significant secondary mass contaminants. Finally, quantitative numerical values—not simple pass/fail statements—must be provided for solubility, appearance, moisture content, TFA residue, and endotoxin levels. PX1 Research publishes full, unedited COAs directly accessible to verified laboratory account holders.
When designing comparative neurological or gene-expression studies, researchers often evaluate Pinealon alongside other short synthetic peptides and regulatory sequences. Each compound presents distinct binding profiles, target tissues, and mechanistic pathways within preclinical models.
In cellular stress and chromatin-interaction protocols, Pinealon (Glu-Asp-Arg) is frequently compared to Epitalon (Ala-Glu-Asp-Gly), a tetrapeptide bioregulator extensively studied for telomerase modulation and neuroendocrine regulation. While Epitalon primarily targets pineal-hypothalamic pathways and chromatin remodeling associated with cellular aging, Pinealon demonstrates higher specificity in direct cortical protection and acute oxidative stress response models. Additionally, researchers comparing central nervous system peptide signaling often contrast these bioregulators with neuropeptides such as Semax, which acts through neurotrophic factor expression (BDNF/NGF) and dopaminergic/serotonergic modulation rather than direct nucleosome binding.
Pinealon is supplied as a lyophilized (freeze-dried) sterile powder to ensure maximum chemical stability during transit and storage. To preserve structural integrity prior to reconstitution, dry lyophilized vials should be kept at -20°C in a desiccated environment.
For laboratory reconstitution, vials should be brought to room temperature before adding a suitable solvent to prevent condensation inside the container. Depending on experimental requirements, Pinealon dissolves readily in sterile bacteriostatic water, sterile 0.9% normal saline, or phosphate-buffered saline (PBS, pH 7.4). Gentle swirl agitation is recommended; high-shear vortexing should be avoided as it can induce mechanical denaturation or aggregation.
Following reconstitution, liquid aliquots should be stored at 2°C to 8°C for short-term experimentation (under 14 days) or frozen at -80°C for long-term storage to prevent peptide hydrolysis. Repeated freeze-thaw cycles must be strictly avoided to prevent sample degradation. Qualified academic and industrial facilities can establish bulk fulfillment schedules via our wholesale portal.
PX1 Research manufactures all research peptides in compliant domestic facilities operating under strict ISO and cGMP-aligned manufacturing frameworks. By maintaining production entirely within the United States, we eliminate foreign supply chain opacity, temperature excursions during international freight, and inconsistent raw material sourcing.
Our facility processes utilize state-of-the-art automated peptide synthesizers, analytical-scale preparative HPLC columns, and specialized lyophilization chambers. Every batch of Pinealon undergoes rigorous lot-level traceability protocols from initial amino acid coupling to final packaging. Orders placed Monday through Friday ship same-day from our distribution hubs in California and Arizona, ensuring fast, temperature-controlled delivery for critical research timelines.
What is Pinealon and what is its primary chemical structure?
Pinealon is a synthetic tripeptide bioregulator with the amino acid sequence L-glutamic acid–L-aspartic acid–L-arginine (Glu-Asp-Arg / E-D-R). It has a theoretical molecular weight of 390.35 g/mol and is studied in preclinical models for its interactions with neuronal chromatin and cellular stress response pathways.
How does PX1 Research verify that Pinealon is third-party tested?
Every lot of Pinealon produced for PX1 Research is submitted to an independent ISO 17025 accredited laboratory for analysis. Verification includes RP-HPLC for purity (>98%), ESI-MS for structural/mass identification, and LAL assays for bacterial endotoxin quantification. Lot-specific COAs are published and accessible to researchers.
What analytical purity level is guaranteed for PX1 Research Pinealon?
PX1 Research guarantees a minimum chromatographic purity of 98.0% as determined by RP-HPLC. Batch reports routinely confirm purities exceeding 99.0% with minimal counterion or water residue.
What are the endotoxin limits for PX1 Research Pinealon?
Our Pinealon batches are tested to ensure endotoxin levels remain below 0.01 EU/μg using quantitative Limulus Amebocyte Lysate (LAL) testing, making the material suitable for sensitive primary cell cultures and in vitro assays.
How should lyophilized Pinealon be stored upon receipt?
Unreconstituted, lyophilized Pinealon powder should be stored at -20°C or -80°C in a dry, dark environment. Stored under these conditions, the peptide maintains chemical stability for up to 24 months.
What solvents are recommended for reconstituting Pinealon for in vitro assays?
Pinealon is highly soluble in aqueous media. Common reconstitution vehicles include sterile bacteriostatic water, 0.9% sterile saline, or standard phosphate-buffered saline (PBS, pH 7.4), depending on the specific cell culture protocol.
Can Pinealon be used in human clinical applications or personal administration?
No. Pinealon provided by PX1 Research is strictly sold as a research chemical intended for in vitro, laboratory, and preclinical experimental applications. It is explicitly not approved for human consumption, medical diagnosis, treatment, or clinical use.
Where is PX1 Research Pinealon manufactured and shipped from?
All PX1 Research peptides are synthesized, purified, and tested within the USA. Orders ship directly from our state-of-the-art distribution centers located in California and Arizona with same-day fulfillment for orders placed Monday through Friday.
All products are sold strictly for laboratory and research use only. Not for human or veterinary use, diagnosis, treatment or consumption. Statements have not been evaluated by the FDA.